Business
Is the CSL (ASX:CSL) vaccine business under threat?
Image source: Getty Images
The CSL Limited (ASX: CSL) share price has been underperforming the ASX 200 in 2021.
Since the start of the year, the biotherapeutics company’s shares are down 2%. This compares to a 10% gain by the benchmark index.
Why is the CSL share price…
Continue Reading
-
Noosa News17 hours agoCrucial step in Sea World helicopter crash investigation set
-
Business17 hours agoWhy Accent, DroneShield, EBR Systems, and Titomic shares are pushing higher
-
Noosa News23 hours agoLocal input into new UN treaty – Proctor
-
General13 hours agoForget a tariff-induced recession, Australians have been in recession for two years